| P2093 | author name string | Priya S Kishnani | |
| | Baodong Sun | |
| | Stephanie Austin | |
| | Haiqing Yi | |
| | Fengqin Gao | |
| P2860 | cites work | Enzyme replacement therapy in the mouse model of Pompe disease | Q44624370 |
| | Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme gene | Q55670773 |
| | Congenital type IV glycogenosis: the spectrum of pleomorphic polyglucosan bodies in muscle, nerve, and spinal cord with two novel mutations in the GBE1 gene | Q57636973 |
| | Immune modulation in Pompe disease treated with enzyme replacement therapy | Q84997571 |
| | Enzyme replacement therapy induces T-cell responses in late-onset Pompe disease | Q85000955 |
| | Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene | Q24336056 |
| | Glycogen metabolism in humans | Q26751151 |
| | Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV) | Q28285077 |
| | A novel mouse model that recapitulates adult-onset glycogenosis type 4 | Q30673108 |
| | Molecular cloning of acid alpha-glucosidase cDNA of Japanese quail (Coturnix coturnix japonica) and the lack of its mRNA in acid maltase deficient quails | Q32068365 |
| | Liver transplantation for type I and type IV glycogen storage disease | Q34280991 |
| | The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies | Q34597246 |
| | Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase | Q35586463 |
| | Persistence of high sustained antibodies to enzyme replacement therapy despite extensive immunomodulatory therapy in an infant with Pompe disease: need for agents to target antibody-secreting plasma cells | Q37012289 |
| | Glycogen and its metabolism: some new developments and old themes | Q37095413 |
| | Liver transplantation in children with glycogen storage disease: controversies and evaluation of the risk/benefit of this procedure | Q37097027 |
| | A Modified Enzymatic Method for Measurement of Glycogen Content in Glycogen Storage Disease Type IV. | Q37415869 |
| | Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers. | Q40483409 |
| | Living Donor Liver Transplantation in a Korean Child with Glycogen Storage Disease Type IV and a GBE1 Mutation. | Q40605304 |
| | Glycogen storage disease type IV, amylopectinosis | Q41825382 |
| | The influence of lysosomes on glycogen metabolism | Q42544859 |
| P921 | main subject | glycogen storage disease | Q1421738 |
| | alglucosidase alfa | Q2919537 |
| | glycogen metabolic process | Q14902477 |
| P304 | page(s) | 31-33 | |
| P577 | publication date | 2016-10-04 | |
| P1433 | published in | Molecular Genetics and Metabolism Reports | Q27725363 |
| P1476 | title | Alglucosidase alfa treatment alleviates liver disease in a mouse model of glycogen storage disease type IV. | |
| P478 | volume | 9 | |